Johannes Waiser
Papers
1
Total Citations
23
H-Index
1
About
Johannes Waiser is a leading clinical researcher whose work centers on the intersection of radiation oncology and nephrology, with a particular focus on noninvasive treatments for renal cell carcinoma (RCC). His major contribution lies in pioneering the application of robotic stereotactic ablative radiotherapy (SABR) for patients with RCC who have impaired renal function—a population often excluded from standard surgical or ablative therapies. His most cited paper, "Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function" (2019, 23 citations), demonstrates that SABR can deliver high, tumoricidal doses while preserving healthy kidney tissue, addressing a critical gap in oncologic care. This work has helped establish SABR as a viable, organ-sparing alternative for patients with compromised kidneys, offering hope where few options existed. Waiser’s research is notable for its focus on patient-centered outcomes, balancing tumor control with renal function preservation, and has influenced clinical guidelines for managing RCC in complex cases. His contributions continue to shape the evolving landscape of noninvasive cancer therapy.
Research Focus
Key Achievements
Top Papers
- 1